,

Curcumin-Based Nanomedicines as Cancer Therapeutics

Specificaties
Paperback, blz. | Engels
Elsevier Science | e druk, 2024
ISBN13: 9780443154126
Rubricering
Elsevier Science e druk, 2024 9780443154126
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

Curcumin-based Nanomedicines as Cancer Therapeutics presents a consistent and thorough overview of nanocurcumin applications in cancer treatments. It brings together the novel applications of nanocurcumin in biological milieu as well as helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries.

Nanocurcumin has been widely explored for the treatment of various cancers; however, the scientific literature is inconsistent in style and structure and scattered across many sources. By providing an explicit account on vital aspects on nanocurcumin-based anticancer delivery approaches and discussing the perspectives of the technologies explored so far based upon the findings outlined, the book offers updated and in-depth knowledge on the topic in one single source written by global leading experts.

In addition, the book aims to stimulate the interest of the academic researchers, industrial scientists, businessmen, and young scholars to address key multidisciplinary challenges faced by nanotechnologists to foster the desired collaboration among biologists, chemists, physicists, engineers, and clinicians to find proper and efficient new cancer treatments.

Specificaties

ISBN13:9780443154126
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

Part-A: Curcumin: Introduction, structure, and physicochemical attributes<br>1. Curcumin: historical background, introduction, structure, and physicochemical attributes<br>2. Curcumin as a pharmaceutical leader<br>3. Chemical structure and molecular targets of curcumin for cancer therapy<br>4. Structural features of curcumin and its effects on cancer-related signaling pathways<br>5. An overview of cellular, molecular, and biological aspect(s) of curcumin in cancer<br><br>Part-B: Smart drug delivery approaches for curcumin delivery in cancer therapy<br>6. Curcumin-drug conjugate-based drug delivery as cancer therapeutics<br>7. Curcumin microcapsule-based drug delivery as cancer therapeutics<br><br>Part-C: Recent advances and regulatory aspects of gold nanoparticles<br>8. Nanoemulsion-based curcumin delivery systems as cancer therapeutics<br>9. Micelle-based curcumin delivery systems as cancer therapeutics<br>10. Liposome-based curcumin delivery systems as cancer therapeutics<br>11. Inorganic nanoparticle-based curcumin delivery as cancer therapeutics<br>12. PLGA nanoparticle-based curcumin delivery as cancer therapeutics<br>13. Polymersomes-based curcumin delivery as cancer therapeutics<br><br>Part-D: Recent advances in nanocurcumin delivery in cancer therapy<br>14. Biopolymer-based formulations for curcumin delivery toward cancer management<br>15. Nanohybrid drug delivery approach as a novel opportunity for curcumin delivery in cancer<br>16. Codelivery of curcumin and siRNA as anticancer therapeutics<br><br>Part-E: Challenges and future perspectives of nano-curcumin drug delivery<br>17. Challenges associated with nanocurcumin anticancer drug delivery systems<br>18. Curcumin-loaded nanoparticles used for in vivo cancer models: an approach about their physicochemical properties and mechanism of action<br>19. Clinical trials, patents, and marketed products of nanocurcumin-based anticancer drug delivery systems

Rubrieken

    Personen

      Trefwoorden

        Curcumin-Based Nanomedicines as Cancer Therapeutics